Proteomics International to patent biomarkers for diagnosis of endometriosis

Newly identified biomarkers via the Promarker™ platform provide a breakthrough for Proteomics International in the effort to create a world-first test for endometriosis.

Patent application filed for the invention, which uses protein biomarkers taken via a standard blood sample as a novel test for diagnosing endometriosis.

Media Release


  • This field is for validation purposes and should be left unchanged.